Tatalaksana terkini pada miastenia gravis
Myasthenia gravis (MG) is a disorder of the neuromuscular junction that causes fluctuating muscle weakness. The etiology of this disease is due to the presence of antibodies that attack acetylcholine receptors on the postsynaptic membrane (autoimmune). Myasthenia gravis is a chronic disease and most...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Universitas Andalas
2022-10-01
|
| Series: | Majalah Kedokteran Andalas |
| Subjects: | |
| Online Access: | https://jurnalmka.fk.unand.ac.id/index.php/art/article/view/1076 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850194862388805632 |
|---|---|
| author | Lydia Susanti |
| author_facet | Lydia Susanti |
| author_sort | Lydia Susanti |
| collection | DOAJ |
| description | Myasthenia gravis (MG) is a disorder of the neuromuscular junction that causes fluctuating muscle weakness. The etiology of this disease is due to the presence of antibodies that attack acetylcholine receptors on the postsynaptic membrane (autoimmune). Myasthenia gravis is a chronic disease and most MG patients fall into Generalized Myasthenia Gravis (gMG) within 2 years of onset. Myasthenic crisis is a serious condition and requires high-cost management. Therefore, disease management continues to be updated to reduce mortality and mortality, as well as improve quality of life. This article discusses the latest
myasthenia gravis; guidelines 2020 ; immunosuppressants; plasmaparesis; ivig |
| format | Article |
| id | doaj-art-a76120d9fa4b4baca51cc6b48e9593de |
| institution | OA Journals |
| issn | 0126-2092 2442-5230 |
| language | English |
| publishDate | 2022-10-01 |
| publisher | Universitas Andalas |
| record_format | Article |
| series | Majalah Kedokteran Andalas |
| spelling | doaj-art-a76120d9fa4b4baca51cc6b48e9593de2025-08-20T02:13:53ZengUniversitas AndalasMajalah Kedokteran Andalas0126-20922442-52302022-10-0145456457410.25077/mka.v45.i4.p564-574.2022656Tatalaksana terkini pada miastenia gravisLydia Susanti0Neurology departemen Medical Faculty Andalas University M Djamil Hospital PadangMyasthenia gravis (MG) is a disorder of the neuromuscular junction that causes fluctuating muscle weakness. The etiology of this disease is due to the presence of antibodies that attack acetylcholine receptors on the postsynaptic membrane (autoimmune). Myasthenia gravis is a chronic disease and most MG patients fall into Generalized Myasthenia Gravis (gMG) within 2 years of onset. Myasthenic crisis is a serious condition and requires high-cost management. Therefore, disease management continues to be updated to reduce mortality and mortality, as well as improve quality of life. This article discusses the latest myasthenia gravis; guidelines 2020 ; immunosuppressants; plasmaparesis; ivighttps://jurnalmka.fk.unand.ac.id/index.php/art/article/view/1076myasthenia gravisguidelines 2020immunosuppressantsplasmaparesisivig |
| spellingShingle | Lydia Susanti Tatalaksana terkini pada miastenia gravis Majalah Kedokteran Andalas myasthenia gravis guidelines 2020 immunosuppressants plasmaparesis ivig |
| title | Tatalaksana terkini pada miastenia gravis |
| title_full | Tatalaksana terkini pada miastenia gravis |
| title_fullStr | Tatalaksana terkini pada miastenia gravis |
| title_full_unstemmed | Tatalaksana terkini pada miastenia gravis |
| title_short | Tatalaksana terkini pada miastenia gravis |
| title_sort | tatalaksana terkini pada miastenia gravis |
| topic | myasthenia gravis guidelines 2020 immunosuppressants plasmaparesis ivig |
| url | https://jurnalmka.fk.unand.ac.id/index.php/art/article/view/1076 |
| work_keys_str_mv | AT lydiasusanti tatalaksanaterkinipadamiasteniagravis |